Bone marrow transplantation in first remission

Leukemia

Volumn 11, Issue SUPPL. 4, 1997, Pages

  Rowe, Jacob M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

ALL; Allogeneic bmt; AML; Autologous bmt; Complete remission; Leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; HUMAN; LEUKEMIA CELL; LEUKEMIA REMISSION; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION;

EID: 0030979462     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Kantarjian HM, Walters RS, Keating MJ, et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990;8:994-1004.
2. Labopin M, Gorin NC: Autologous bone marrow transplantation in 2,505 patients with acute leukemia in Europe: a retrospective study. Leukemia 1992; 6(suppl4): 95-99.
3. Uckun FM, Kersey JH, Haake R, et al. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 1993; 329:1296-1301.
4. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977; 49: 511-533.
5. Doney K, Fisher LD, Appelbaum FR, et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versushost disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991 ; 7:453-459.